Variant report
Variant | esv3324146 |
---|---|
Chromosome Location | chr13:89034101-89037599 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186377551 | chr13:89034165-89034166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144790328 | chr13:89034179-89034180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546845933 | chr13:89034180-89034181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547305574 | chr13:89034187-89034188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114166397 | chr13:89034229-89034230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148582656 | chr13:89034269-89034270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs539864364 | chr13:89034313-89034314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558494097 | chr13:89034345-89034346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528806280 | chr13:89034348-89034349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114732633 | chr13:89034424-89034425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562442657 | chr13:89034425-89034426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534301164 | chr13:89034442-89034443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566568854 | chr13:89034466-89034467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190689380 | chr13:89034469-89034470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182925187 | chr13:89034485-89034486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560473328 | chr13:89034494-89034495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527552370 | chr13:89034511-89034512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs546691562 | chr13:89034533-89034534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571574032 | chr13:89034546-89034547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532501270 | chr13:89034622-89034623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551099610 | chr13:89034634-89034635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188268551 | chr13:89034746-89034747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532289538 | chr13:89034793-89034794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374381139 | chr13:89034837-89034838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536482049 | chr13:89034896-89034897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551997661 | chr13:89034914-89034915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554721416 | chr13:89034915-89034916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192550169 | chr13:89034978-89034979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9520466 | chr13:89035009-89035010 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs142998724 | chr13:89035056-89035057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs151137202 | chr13:89035057-89035058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543857539 | chr13:89035065-89035066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs577630267 | chr13:89035116-89035117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs338694 | chr13:89035127-89035128 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs574566123 | chr13:89035134-89035135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551742692 | chr13:89035302-89035303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542064731 | chr13:89035304-89035305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560352034 | chr13:89035309-89035310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs11069690 | chr13:89035453-89035454 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs546030462 | chr13:89035516-89035517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183234520 | chr13:89035527-89035528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139128690 | chr13:89035528-89035529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532578122 | chr13:89035578-89035579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143996726 | chr13:89035594-89035595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562670400 | chr13:89035602-89035603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573509025 | chr13:89035648-89035649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187766186 | chr13:89035687-89035688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs75099137 | chr13:89035714-89035715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs76306576 | chr13:89035741-89035742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534129228 | chr13:89035775-89035776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:89028000-89036200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr13:89035800-89037400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr13:89036200-89038200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:89036400-89036800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr13:89036600-89037000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr13:89036600-89037600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr13:89036800-89037000 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
8 | chr13:89036800-89037800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr13:89037000-89037200 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
10 | chr13:89037200-89037400 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |